Multiplex Automated Genome Engineering
US 8,569,041 B2
Source verified
What the document is
A granted United States patent covering automated methods for introducing many nucleic acid sequences into target cells at once. The technique is known as MAGE, multiplex automated genome engineering, and it is a foundational tool for editing a genome at many sites in parallel rather than one at a time. Priority runs back to 2006, and the patent published on October 29, 2013.
Why it is in the report
Read the front page next to the Harvard review in this same library. The lead inventor is the geneticist whose laboratory appears in that review, and the assignee is Harvard College itself. Two documents, two institutions, one name, both public. That is what a convergence looks like when it is documented rather than alleged.
What this document does not say. A patent is a claim of invention, not evidence of wrongdoing, and genome engineering tools like this one underpin ordinary medical research worldwide. This record establishes an inventor, an assignee, and a date. It establishes nothing else, and this library will not stretch it further. Assignee listings can also change hands over time, so confirm the current assignee at the source.
Pull it yourself
- Open Google Patents or the USPTO full text search.
- Enter the patent number US8569041B2.
- Read the title, assignee, priority date, and first claim.
Cite this record
United States Patent and Trademark Office. Multiplex Automated Genome Engineering. Granted patent, 2013-10-29. https://patents.google.com/patent/US8569041B2/en
